Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pariser

Showing results (111-120 of 193) with videos related to

Pageof 20
Sort By:
Journal of Drugs in Dermatology : JDD|June 20, 2017
Safety and Efficacy of Escalating Doses of Ingenol Mebutate for Field Treatment of Actinic Keratosis on the Full Face, Full Balding Scalp, or ChestC William Hanke, Brian Berman, Neil Swanson, et al.
International Journal of Dermatology|June 7, 2007
Transitioning patients from efalizumab to alternative psoriasis therapies: findings from an open-label, multicenter, Phase IIIb studyAlan Menter, Tiffani K Hamilton, Darryl P Toth, et al.
Journal of the American Academy of Dermatology|September 19, 2018
Long-term safety results from a phase 3 open-label study of a fixed combination halobetasol propionate 0.01% and tazarotene 0.045% lotion in moderate-to-severe plaque psoriasisMark G Lebwohl, Jeffrey L Sugarman, Linda Stein Gold, et al.
BMC Neuroscience|May 13, 2024
Characterizing dysregulations via cell-cell communications in Alzheimer's brains using single-cell transcriptomesChe Yu Lee, Dylan Riffle, Yifeng Xiong, et al.
Journal of the American Academy of Dermatology|July 14, 2018
Topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Results from the ATMOS-1 and ATMOS-2 phase 3 randomized controlled trialsDee Anna Glaser, Adelaide A Hebert, Alexander Nast, et al.
Journal of the American Academy of Dermatology|April 4, 2018
Safety and efficacy of a fixed combination of halobetasol and tazarotene in the treatment of moderate-to-severe plaque psoriasis: Results of 2 phase 3 randomized controlled trialsLinda Stein Gold, Mark G Lebwohl, Jeffrey L Sugarman, et al.
American Journal of Clinical Dermatology|May 22, 2019
A 44-Week Open-Label Study Evaluating Safety and Efficacy of Topical Glycopyrronium Tosylate in Patients with Primary Axillary HyperhidrosisDee Anna Glaser, Adelaide A Hebert, Alexander Nast, et al.
Pediatric Dermatology|November 21, 2015
Scanning Electron Microscopic Hair Shaft Analysis in Ectodermal Dysplasia SyndromesStefanie A Hirano-Ali, Ashley M Reed, Brandon J Rowan, et al.
The British Journal of Dermatology|May 7, 2009
Effects of pimecrolimus cream 1% in the treatment of patients with atopic dermatitis who demonstrate a clinical insensitivity to topical corticosteroids: a randomized, multicentre vehicle-controlled trialD Y M Leung, J M Hanifin, D M Pariser, et al.
Journal of the American Academy of Dermatology|November 26, 1999
A double-blind, placebo-controlled study of topical tetracaine in the treatment of herpes labialisL H Kaminester, R J Pariser, D M Pariser, et al.
Pageof 20

Showing results (111-120 of 193) with videos related to

Sort By:
Pageof 20
Journal of Drugs in Dermatology : JDD|June 20, 2017
Safety and Efficacy of Escalating Doses of Ingenol Mebutate for Field Treatment of Actinic Keratosis on the Full Face, Full Balding Scalp, or ChestC William Hanke, Brian Berman, Neil Swanson, et al.
International Journal of Dermatology|June 7, 2007
Transitioning patients from efalizumab to alternative psoriasis therapies: findings from an open-label, multicenter, Phase IIIb studyAlan Menter, Tiffani K Hamilton, Darryl P Toth, et al.
Journal of the American Academy of Dermatology|September 19, 2018
Long-term safety results from a phase 3 open-label study of a fixed combination halobetasol propionate 0.01% and tazarotene 0.045% lotion in moderate-to-severe plaque psoriasisMark G Lebwohl, Jeffrey L Sugarman, Linda Stein Gold, et al.
BMC Neuroscience|May 13, 2024
Characterizing dysregulations via cell-cell communications in Alzheimer's brains using single-cell transcriptomesChe Yu Lee, Dylan Riffle, Yifeng Xiong, et al.
Journal of the American Academy of Dermatology|July 14, 2018
Topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Results from the ATMOS-1 and ATMOS-2 phase 3 randomized controlled trialsDee Anna Glaser, Adelaide A Hebert, Alexander Nast, et al.
Journal of the American Academy of Dermatology|April 4, 2018
Safety and efficacy of a fixed combination of halobetasol and tazarotene in the treatment of moderate-to-severe plaque psoriasis: Results of 2 phase 3 randomized controlled trialsLinda Stein Gold, Mark G Lebwohl, Jeffrey L Sugarman, et al.
American Journal of Clinical Dermatology|May 22, 2019
A 44-Week Open-Label Study Evaluating Safety and Efficacy of Topical Glycopyrronium Tosylate in Patients with Primary Axillary HyperhidrosisDee Anna Glaser, Adelaide A Hebert, Alexander Nast, et al.
Pediatric Dermatology|November 21, 2015
Scanning Electron Microscopic Hair Shaft Analysis in Ectodermal Dysplasia SyndromesStefanie A Hirano-Ali, Ashley M Reed, Brandon J Rowan, et al.
The British Journal of Dermatology|May 7, 2009
Effects of pimecrolimus cream 1% in the treatment of patients with atopic dermatitis who demonstrate a clinical insensitivity to topical corticosteroids: a randomized, multicentre vehicle-controlled trialD Y M Leung, J M Hanifin, D M Pariser, et al.
Journal of the American Academy of Dermatology|November 26, 1999
A double-blind, placebo-controlled study of topical tetracaine in the treatment of herpes labialisL H Kaminester, R J Pariser, D M Pariser, et al.
Pageof 20